Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
60.72 USD | +0.59% | -0.94% | +10.36% |
05-21 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
05-20 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.36% | 1.17B | |
+38.83% | 728B | |
+33.28% | 603B | |
-5.16% | 360B | |
+20.17% | 332B | |
+2.05% | 279B | |
+16.13% | 244B | |
+7.98% | 207B | |
-5.52% | 205B | |
+6.12% | 164B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q1 Revenue $137.4M, vs. Street Est of $126M